Understanding the Development of Compensatory Pathways in a Mutant Malaria Parasite Harbouring Hypomorphic Allele of Plant-Like Kinases
November 22nd, 2024
Chemical genetics involves the substitution of a gatekeeper residue with an amino acid containing a different side chain at the target locus. Here, we have generated a mutant parasite containing a hypomorphic allele of cdpk1 and identified compensatory pathways adopted by the parasite in the mutant background.
Drug resistance is a major challenge in combating malaria. Our study aims to identify compensatory pathways in malaria parasites containing hypomorphic allele of essential protein kinases. Targeting two kinases simultaneously may be a better strategy that avoids developing drug resistance against individual kinases.
Gene editing using CRISPR-Cas9 has profoundly benefited malaria research and has been instrumental performing allelic exchanges, endogenous tagging, conditional knockout, and knockdown of target gene. The molecular mechanism of drug resistance, understanding target gene function and study of host parasite interaction can now be studied with greater ease. The current experimental challenges include heterologous protein expression in E.coli due to the high richness of the plasmodium genome.
Additionally, of target effect of CRISPR-Cas9 complicated data interpretation and led to erroneous results. Low transcription efficiency with the malaria parasite increases the time required for generating the desired genetic modification. Our findings suggests that targeting a single kinase in the malaria parasite may lead to compensatory over expression of other kinases.
This raises new question about the potential for adaptive resistance and whether dual kinase inhibition could effectively prevent such adaptation, opening avenues for the combination therapeutic strategies. In the future, our laboratory will target other essential protein kinases of malaria parasites using chemical genetics. Transcriptional rewiring in the mutant parasites will help in identifying compensatory pathways that may be simultaneously targeted to prevent development of drug resistance against individual kinases.
Overview
This study investigates the compensatory pathways in malaria parasites with a hypomorphic allele of essential protein kinases. The research emphasizes the potential for dual kinase inhibition as a strategy to circumvent drug resistance.
Key Study Components
Research Area
- Malaria drug resistance
- Protein kinase function
- Compensatory genetic mechanisms
Background
- Drug resistance in malaria poses significant challenges for treatment.
- The study explores the genetic alterations that occur in parasites under drug pressure.
- CRISPR-Cas9 technology is employed in genetic modifications of the malaria parasites.
Methods Used
- Gene editing using CRISPR-Cas9
- Malaria parasites
- Experimental analysis of kinase activity and genetic expressions
Main Results
- The findings indicate that inhibiting a single kinase may lead to compensatory expression of others.
- Adaptive resistance mechanisms in response to kinase inhibition were identified.
- The research suggests dual kinase targeting could effectively prevent resistance.
Conclusions
- This study highlights the adaptive strategies of malaria parasites in response to genetic manipulation.
- The findings may inform future therapeutic strategies to combat drug resistance in malaria.
Frequently Asked Questions
Chapters in this video
0:00
Introduction
2:02
In Vitro Culturing of Plasmodium falciparum and Sorbitol Synchronization for Transfection to Unravel Compensatory Mechanisms Using CDPK1
3:12
Transfection of Ring Stage Malarial Parasite with Plasmids Functional for Rewiring the Transcriptome
6:00
PCR Verification of Transgenic Parasite with Desired Modification of CDPK1 Locus for Elucidating Plasmodium falciparum Kinase Resistance Mechanisms
7:14
Limiting Dilution for Obtaining Clonal Transgenic Plasmodium Parasites for Combating Drug Resistance in Malaria
